Rosuvastatin
Crestor, EZALLOR SPRINKLE
HMG-CoA Reductase Inhibitor
NADAC/unit
$0.0345
No Shortage
Tier 1: 286.9%
18 Manufacturers
72 ANDAs
Rosuvastatin lowers LDL cholesterol and triglycerides to reduce cardiovascular risk.
vs. brand Crestor: Generic saves up to 100% per unit
Market Intelligence
2026-01-14 Class II Recall: AvKARE
2025-04-16 Class II Recall: Glenmark Pharmaceuticals Inc., USA
2023-04-12 Class II Recall: Preferred Pharmaceuticals, Inc.
2023-03-08 Class II Recall: Accord Healthcare, Inc.
2023-03-08 Class II Recall: Accord Healthcare, Inc.
Generic Manufacturers
ACCORD HEALTHCARE INCALKEM LABORATORIES LTDASTRAZENECA UK LTDAUROBINDO PHARMA LTDBIOCON PHARMA LTDCADILA PHARMACEUTICALS LTDCHANGZHOU PHARMACEUTICAL FACTORYCHARTWELL RX SCIENCES LLCGLENMARK SPECIALTY SAHETERO LABS LTD UNIT VMSN LABORATORIES PRIVATE LTDRENATA PLCSCIEGEN PHARMACEUTICALS INCSHANDONG NEW TIME PHARMACEUTICAL CO LTDTORRENT PHARMACEUTICALS LTDUMEDICA LABORATORIES PRIVATE LTDWATSON LABORATORIES INCZHEJIANG JINGXIN PHARMACEUTICAL CO LTDZHEJIANG YONGTAI PHARMACEUTICAL CO LTD
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.